Skip to main content
. 2022 Jan 6;11:799566. doi: 10.3389/fonc.2021.799566

Figure 4.

Figure 4

Impact of ZCCHC17 on survival in HCC patients from different cohorts. (A–C) The expression of ZCCHC17 was significantly related to patients’ OS (P= 0.004), PFS (P=0.0032) and DSS (P=0.003) in TCGA; (D) High methylation level of cg08734125 is relevant to the patient’s better OS (P=0.011) in TCGA; (E, F) Low methylation level of cg25469212 is relevant to the patient’s worse OS(P=0.027) and PFS (P= 0.049) in TCGA; (G) The poor OS correlated with high ZCCHC17 expression in ICGC(P=0.006); (H) High expression of ZCCHC17 indicates a poor OS in the validation cohort. (P= 0.0015).